Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

NEW YORK--( BUSINESS WIRE )--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of those who acquired Rite Aid Corporation (“Rite Aid” or the “Company”) (NYSE: RAD) securities between April 14, 2022 through September 28, 2022 (the “Class Period”). Investors have until December 19, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Rite Aid Corporation (RAD) Investors and Encourages Investors to Contact the Firm Before December 19, 2022

Rite Aid Corporation (NYSE:RAD ) Credit Suisse 31st Annual Healthcare Conference Call November 9, 0000 4:25 PM ET Company Participants Heyward Donigan - CEO Matt Schroeder - CFO Conference Call Participants Albert Rice - Credit Suisse Albert Rice Hi, everyone. I'm A.J. Rice, the Health Care Services Analyst at Credit Suisse.

Rite Aid Corporation (RAD) Presents at Credit Suisse 31st Annual Healthcare Conference Transcript

NEW YORK , Nov. 11, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 14, 2022 and September 28, 2022, both dates inclusive (the "Class Period"), of the important December 19, 2022 lead plaintiff deadline. SO WHAT: If you purchased Rite Aid securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A TOP RANKED LAW FIRM, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - RAD

San Diego, California--(Newsfile Corp. - November 4, 2022) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rite Aid Corporation (NYSE: RAD) securities between April 14, 2022 and September 28, 2022, both dates inclusive (the "Class Period") have until December 19, 2022 to seek appointment as lead plaintiff in the Rite Aid class action lawsuit. Captioned Page v. Rite Aid Corporation, No. 22-cv-04201 (E.D. Pa.

INVESTOR ALERT: Investors in Rite Aid Corporation with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RAD

NEW YORK , Nov. 4, 2022 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 14, 2022 and September 28, 2022, both dates inclusive (the "Class Period"), of the important December 19, 2022 lead plaintiff deadline. SO WHAT: If you purchased Rite Aid securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - RAD

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) announced today that President and CEO Heyward Donigan and CFO Matt Schroeder will present at the Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes, California, on November 9th at 4:25 p.m.

Rite Aid President and CEO Heyward Donigan to Present at Credit Suisse 31st Annual Healthcare Conference

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) (“we,” “us,” “our” or the “Company”) today announced that it has commenced a tender offer (the “Tender Offer”) to purchase for cash up to $200 million aggregate purchase price (not including any accrued and unpaid interest, and as such amount may be increased or decreased by the Company, the “Aggregate Maximum Purchase Price”) of the Company's outstanding 7.500% Senior Secured Notes due 2025 (the “Notes”).

Rite Aid Announces Cash Tender Offer and Consent Solicitation for up to $200,000,000 Aggregate Purchase Price of 7.500% Senior Secured Notes Due 2025

NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Rite Aid securities between March 16, 2018 and August 29, 2022, both dates inclusive (the “Class Period”).

Bronstein, Gewirtz & Grossman, LLC, A Top Firm, Notifies Rite Aid Corporation (RAD) Investors of Class Action and Encourages Investors to Actively Participate

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Rite Aid business and prospects, resulting in its stock trading at inflated prices.

INVESTOR DEADLINE: Investors in Rite Aid Corporation with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RAD

NEW YORK , Oct. 27, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 14, 2022 and September 28, 2022, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - RAD

PHILADELPHIA--(BUSINESS WIRE)--As the U.S. Centers for Disease Control & Prevention (CDC) warns of early increases in seasonal influenza cases, Rite Aid (NYSE: RAD) addresses common misperceptions about vaccination and stresses the importance of staying up to date on flu and COVID-19 vaccinations before Halloween.

Costumes, Candy, and Vaccinations – Rite Aid Shares Reasons to Add Flu and COVID-19 Vaccinations to Your Halloween Check List

LOS ANGELES, CA / ACCESSWIRE / October 25, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rite Aid Corporation ("Rite Aid" or "the Company") (NYSE:RAD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Rite Aid Corporation with Losses to Contact the Firm

The beleaguered drugstore company's shares got a shot in the arm from President Joe Biden.

Why Rite Aid's Shares Jumped 15.3% on Tuesday

San Diego, California--(Newsfile Corp. - October 25, 2022) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rite Aid Corporation (NYSE: RAD) securities between April 14, 2022 and September 28, 2022, inclusive (the "Class Period") have until December 19, 2022 to seek appointment as lead plaintiff in the Rite Aid class action lawsuit. Captioned Page v. Rite Aid Corporation, No. 22-cv-04201 (E.D. Pa.

INVESTOR ALERT: Rite Aid Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RAD

NEW YORK--(BUSINESS WIRE)---- $RAD #classaction--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of those who acquired Rite Aid Corporation (“Rite Aid” or the “Company”) (NYSE: RAD) securities between April 14, 2022 through September 28, 2022 (the “Class Period”).

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Rite Aid Corporation (RAD) Investors

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 14, 2022 and September 28, 2022, both dates inclusive (the “Class Period”).

EQUITY ALERT: Rosen Law Firm Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RAD

Rite Aid (RAD) remains well-placed on online strength, increased non-COVID prescriptions and cost initiatives despite muted COVID-19 testing and vaccine demand, and supply-chain issues.

Online Strength to Drive Rite Aid (RAD) Amid Supply-Chain Woes

LOS ANGELES, CA / ACCESSWIRE / October 24, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rite Aid Corporation ("Rite Aid" or "the Company") (NYSE:RAD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Rite Aid Corporation with Losses to Contact the Firm

SAN DIEGO , Oct. 21, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rite Aid Corporation (NYSE: RAD) securities between April 14, 2022 and September 28, 2022, both dates inclusive (the "Class Period") have until December 19, 2022 to seek appointment as lead plaintiff in the Rite Aid class action lawsuit. Captioned Page v.

INVESTOR NOTICE: Rite Aid Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RAD

SAN DIEGO--(BUSINESS WIRE)---- $RAD #RAD--Rite Aid Corporation (RAD) Misrepresented the Number of New Members Added by its Elixir Subsidiary

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Rite Aid Corporation (RAD)

Did you lose money on investments in Rite Aid? If so, please visit Rite Aid Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.

RITE AID CORPORATION (RAD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Rite Aid Corporation (RAD)

CVS Health

Walgreens

The Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain from the growing demand for digital healthcare support. However, reimbursement challenges are hurting overall industry health.

3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Challenges

INVESTOR ALERT: Rite Aid Corporation Investors with Substantial Losses Have Opportunity to Lead the Rite Aid Class Action Lawsuit - RAD

LOS ANGELES--(BUSINESS WIRE)---- $RAD #RAD--The Schall Law Firm Encourages Investors in Rite Aid Corporation with Losses of $100,000 to Contact the Firm

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Rite Aid Corporation with Losses of $100,000 to Contact the Firm

NEW YORK , Oct. 19, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 22-cv-04201, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Rite Aid securities between April 14, 2022 and September 28, 2022, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

News for Rite Aid Stock (RAD)